DCM
ICPT

DAFNA Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

DAFNA Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,430
Closed -$403K – 83
2015
Q3 		$403K Buy
2,430
+430
+22% +$94.6K 0.4% 62
2015
Q2 		$483K Hold
2,000
– – 0.41% 52
2015
Q1 		$564K Sell
2,000
-19,900
-91% -$4.31M 0.43% 46
2014
Q4 		$3.42M Buy
21,900
+19,900
+995% +$3.68M 2.7% 11
2014
Q3 		$473K Hold
2,000
– – 0.48% 38
2014
Q2 		$473K Hold
2,000
– – 0.45% 34
2014
Q1 		$660K Sell
2,000
-7,598
-79% -$2.56M 0.57% 35
2013
Q4 		$655K Hold
9,598
– – 0.67% 33
2013
Q3 		$663K Sell
9,598
-402
-4% -$19.8K 0.72% 36
2013
Q2 		$448K Buy
+10,000
New +$342K 0.66% 35

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $431B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return